Laird Norton Wetherby Trust Company’s Medtronic MDT Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.71M	Sell	21,687 -6,679	-24%	-$539K	0.03%	375
2026 Q1	$2.48M	Sell	28,366 -1,617	-5%	-$155K	0.05%	277
2025 Q4	$2.9M	Buy	+29,983	New	+$2.91M	0.06%	247
2022 Q2	–	Sell	-2,628	Closed	-$291K	–	162
2022 Q1	$291K	Buy	2,628 +412	+19%	+$43.5K	0.03%	149
2021 Q4	$229K	Sell	2,216 -136	-6%	-$15.7K	0.02%	176
2021 Q3	$294K	Buy	2,352 +238	+11%	+$30.8K	0.03%	143
2021 Q2	$262K	Buy	2,114 +218	+11%	+$27.4K	0.03%	127
2021 Q1	$222K	Hold	1,896	–	–	0.02%	141
2020 Q4	$222K	Buy	+1,896	New	+$209K	0.02%	137

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Laird Norton Wetherby Trust Company's MDT Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Medtronic (MDT) stake by 24% in Q2 2026, selling an estimated $539K and leaving 21,687 shares worth $1.71M. The position accounts for 0.03% of the portfolio, ranked #375.

Laird Norton Wetherby Trust Company first reported a position in MDT in Q4 2020 and has held it in 9 quarters since. The position peaked at $2.9M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Laird Norton Wetherby Trust Company held 21,687 shares of Medtronic worth $1.71M as of Q2 2026.
Laird Norton Wetherby Trust Company sold 6,679 Medtronic shares in Q2 2026, an estimated $539K.
Medtronic made up 0.03% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #375 holding.
Laird Norton Wetherby Trust Company first reported a position in Medtronic in Q4 2020 and has held it in 9 quarters since.
Laird Norton Wetherby Trust Company's Medtronic position peaked at $2.9M in Q4 2025.
2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.